Tangled wire in a Dacron band during Cardioband transcatheter tricuspid annuloplasty-How to solve the problem.
transcatheter tricuspid valve intervention (TTVI)
transesophageal echocardiography (TEE)
tricuspid annuloplasty
tricuspid regurgitation (TR)
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
revised:
29
01
2020
received:
17
12
2019
accepted:
04
03
2020
pubmed:
11
3
2020
medline:
21
9
2021
entrez:
11
3
2020
Statut:
ppublish
Résumé
Transcatheter tricuspid valve intervention (TTVI) is an emerging treatment for patients with symptomatic severe tricuspid regurgitation (TR). Currently, the issues that arise during TTVI are unclear. Here, a 78-year-old woman with severe TR underwent transcatheter tricuspid valve annuloplasty using a Cardioband (Edwards Lifesciences, Irvine, CA). We attempted to cinch the Dacron band after anchoring; however, it was impossible to connect the distal tip of the size adjustment tool and the Dacron band because the cinching wire was tangled around the Dacron band. We resolved this issue without surgical intervention, and eventually cinched the annulus. Final echocardiography revealed dramatic TR reduction. To our knowledge, no study has reported a tangled wire in a Dacron band during Cardioband use. Clinicians should be aware of the risks accompanying this concern in case where it is impossible to connect the distal tip of the size adjustment tool and the Dacron band during cinching.
Substances chimiques
Polyethylene Terephthalates
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E724-E726Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405-409.
Lee JW, Song JM, Park JP, Lee JW, Kang DH, Song JK. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J. 2010;74:375-380.
Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, Pislaru S, Park S, Mahoney DW, Biner S and others. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imag 2014;7:1185-1194.
Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019;40:476-484.
Chorin E, Rozenbaum Z, Topilsky Y, et al. Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imag. 2020;21:157-165.
Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:2998-3008.
Taramasso M, Hahn RT, Alessandrini H, et al. The international multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv. 2017;10:1982-1990.
Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry. JACC Cardiovasc Interv. 2019;12:155-165.
Mehr M, Taramasso M, Besler C, et al. 1-year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve registry. JACC Cardiovasc Interv. 2019;12:1451-1461.
Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135:1802-1814.
Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019;394:2002-2011.
Nickenig G, Weber M, Schueler R, et al. 6-month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J Am Coll Cardiol. 2019;73:1905-1915.
Miura M, Maisano F, Zuber M, et al. Novel transcatheter therapies for treating tricuspid regurgitation. Minerva Cardioangiol. 2019;67:223-233.
Tabata N, Sugiura A, Tsujita K, Nickenig G, Sinning JM. Percutaneous interventions for mitral and tricuspid heart valve diseases. Cardiovasc Interv Ther. 2020;35:62-71.